Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

NCT05596890 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Patient-reported Outcomes
Immunotherapy

Interventions

DRUG: Paclitaxel-albumin
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Tislelizumab
RADIATION: VMAT or IMRT
PROCEDURE: Esophagectomy

Sponsor

Guangdong Provincial People's Hospital